What is Acomplia?
Acomplia is drug by Sanofi for the treatment of obesity and to help people to stop smoking.

When will the FDA approve Acomplia?

Currently the FDA is reviewing Rimonabant for approval as a prescription drug and the drug's maker anticipates approval this year.

How does Acomplia work?

Acomplia works as a behavioral drug by affecting receptors in the brain that play a role in compulsive behaviors such as overeating and smoking. It is not an appetite suppressant.

What are the benefits?

It was found in a recent study published last month that people who took the drug lost 4.5 percent of their body weight. The same study also found that people who stopped taking the drug regained the weight they lost.

What are the side effects of Acomplia?

The reported side effects have been nausea, anxiety and depressed mood.

How useful is Acomplia?

The medication Acomplia works by being a cannabinoid receptor antagonist. Simply it prevents the normal action of endogenous cannabinoid in the brain from stimulating the so-called CB1 receptors. By doing this it helps in controlling appetite and also aids people to stop smoking and even improves cholesterol ratios.

How does Acomplia help in stopping smoking?

It works by targeting the Endocannabinoid system, which controls the urge to smoke and wean smokers off cigarettes by slowly reducing their dependence on nicotine.